GILD NASDAQ
Gilead Sciences, Inc.
1W: +3.7%
1M: +5.1%
3M: +18.1%
YTD: +30.5%
1Y: +32.3%
3Y: +118.5%
5Y: +182.7%
$159.08
+0.39 (+0.25%)
After Hours: $158.15 (-0.93, -0.58%)
Weekly Expected Move ±4.0%
$144
$150
$156
$162
$169
Credit Risk of going bust: lower than 84% of companies Debt: 11.8% of company value Bonds: $407.1M held by 325 funds, 58 bp over Treasuries → details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $1.38 (down 99.1%), Gilead Sciences, Inc. would be worth roughly what it owes.
Total debt $26.25B against a stock market value of $196.77B.
Distance to default 10.79 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $14.33B (short-term plus half of long-term), stock volatility 26.8%; Altman Z 3.79. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
If the stock fell to about $1.38 (down 99.1%), Gilead Sciences, Inc. would be worth roughly what it owes.
Total debt $26.25B against a stock market value of $196.77B.
Distance to default 10.79 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $14.33B (short-term plus half of long-term), stock volatility 26.8%; Altman Z 3.79. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$30B
Revenue
+5.5% YoY
$-3,240M
Net Income
-151.3% YoY
$13B
Free Cash Flow
+40.9% YoY
79.8%
Gross Margin
-133.2%
Op. Margin
-134.5%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-20.6%
ROA-6.2%
ROIC-3.4%
Valuation
P/E-60.9
P/B16.6
EV/EBITDA135.0
Leverage
Debt/Equity2.22
Current Ratio1.27
Interest Cov.-1.4x
Quality Scores
Piotroski F5/9
Altman Z3.16
Beneish M-4.14